GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Pharma Co Ltd (XKRX:032300) » Definitions » Scaled Net Operating Assets

Korea Pharma Co (XKRX:032300) Scaled Net Operating Assets : 0.51 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Korea Pharma Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Korea Pharma Co's operating assets for the quarter that ended in Dec. 2024 was ₩74,692 Mil. Korea Pharma Co's operating liabilities for the quarter that ended in Dec. 2024 was ₩18,044 Mil. Korea Pharma Co's Total Assets for the quarter that ended in Sep. 2024 was ₩111,502 Mil. Therefore, Korea Pharma Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.51.


Korea Pharma Co Scaled Net Operating Assets Historical Data

The historical data trend for Korea Pharma Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korea Pharma Co Scaled Net Operating Assets Chart

Korea Pharma Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only 0.62 0.60 0.40 0.42 0.47

Korea Pharma Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.43 0.46 0.47 0.51

Competitive Comparison of Korea Pharma Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Korea Pharma Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Korea Pharma Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Korea Pharma Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Korea Pharma Co's Scaled Net Operating Assets falls into.


;
;

Korea Pharma Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Korea Pharma Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(74691.951-18043.818)/121303.373
=0.47

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=112386.95 - 37694.999
=74691.951

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=40945.53 - 18646.075 - 4255.637
=18043.818

Korea Pharma Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(74691.951-18043.818)/111501.843
=0.51

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=112386.95 - 37694.999
=74691.951

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=40945.53 - 18646.075 - 4255.637
=18043.818

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Korea Pharma Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Korea Pharma Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Korea Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
8th Floor, 14, Teheran-ro 4-gil, Gangnam-gu, Seoul, KOR
Korea Pharma Co Ltd is a drug manufacturer. The company's products include amino acid drugs; antibiotic drugs; antidotal drugs; antiepileptic drugs; antihistamine drugs; anti-inflammatory drugs; antimicrobial drugs; antiplatelet drugs; circulatory system drugs; cns drugs; dermatological drugs; endocrine drugs; gastrointestinal drugs; hepatic drugs; hormonal drugs; multivitamins; respiratory drugs; skeltal muscle relaxants; specialty drugs; sympathomimetic drugs; and vitamin b1.

Korea Pharma Co Headlines

No Headlines